Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.60 |
| ▸ | CA1 | P00915 | 4/20 | 0.60 |
| ▸ | CA2 | P00918 | 4/20 | 0.60 |
| ▸ | CA7 | P43166 | 4/20 | 0.60 |
| ▸ | CA9 | Q16790 | 4/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | XDH | P47989 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | GFER | P55789 | 1/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.58 |
| ▸ | RELA | Q04206 | 1/20 | 0.58 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9121827 | 1.00 | CA12 (0.60) | CA12CA1CA2CA7CA9 | |
| Methyl Alcohol SCHEMBL28269742 | 0.98 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6734277 | 0.91 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17274803 | 0.91 | CA12 (0.76) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31455886 | 0.91 | CA12 (0.76) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14301421 | 0.91 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1174380 | 0.91 | CA12 (0.76) | CA12CA1CA2CA7CA9 | |
| SCHEMBL166126 | 0.91 | TPMT (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23699475 | 0.89 | KDM4E (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8006121 | 0.89 | KDM4E (0.50) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112778153-B | Amido bridged hexacarboxylic acid ligand and metal organic framework material as well as preparation method and application thereof | 湖南科技大学 | 2023-03-14 | — | — | CN | claimed |
| CN-100363323-C | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEM PATENTS INC (US) | 2008-01-23 | — | — | CN | claimed |
| CN-1726179-A | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEM PATENTS INC (US) | 2006-01-25 | — | — | CN | claimed |
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| CN-118955391-A | Substituted N- (2-oxo ethyl) benzamide derivative and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2024-11-15 | — | — | CN | disclosed |
| EP-4452930-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | Beam Therapeutics Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-20240335543-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | BEAM THERAPEUTICS INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2023121970-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | BEAM THERAPEUTICS INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023121970-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | BEAM THERAPEUTICS INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| CN-112778153-B | Amido bridged hexacarboxylic acid ligand and metal organic framework material as well as preparation method and application thereof | 湖南科技大学 | 2023-03-14 | — | — | CN | disclosed |
| CN-1285815-A | Process for hydrogenating benzenepolycarboxylic acids or derivatives thereof using catalysts containing macropores | BASF AG (DE) | 2001-02-28 | — | — | CN | disclosed |
| EP-0642569-B1 | POLYESTERS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ETHERS | CHEVRON CHEM CO (US) | 1998-12-16 | — | — | EP | disclosed |
| CN-1197453-A | 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors | ZENECA LTD (GB) | 1998-10-28 | — | — | CN | disclosed |
| EP-0842151-A1 | 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | ZENECA LIMITED (GB) | 1998-05-20 | — | — | EP | disclosed |
| WO-1996034851-A1 | BENZENE, PYRIDINE, NAPHTALENE OR BENZOPHENONE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHETASE AND PROTEIN FARNESYLTRANSFERASE | ABBOTT LABORATORIES (US) | 1996-11-07 | — | — | WO | disclosed |
| EP-0642569-A4 | POLYESTERS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ETHERS. | CHEVRON CHEM CO (US) | 1995-08-09 | — | — | EP | disclosed |
| EP-0642569-A1 | POLYESTERS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ETHERS | CHEVRON CHEMICAL COMPANY (US) | 1995-03-15 | — | — | EP | disclosed |
| WO-1994020592-A1 | POLYESTERS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ETHERS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY A DIVISION OF CHEVRON U.S.A. INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| US-5296003-A | Fuel additives | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335543-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | PHOSPHO1, SGMS1, SGMS2 | CA12 711/4885CA1 1198/4885CA2 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.